Contact this trialFirst, we need to learn more about you.
Radioantibody
Ac-225 Rosopatamab Tetraxetan for Prostate Cancer
Recruiting1 awardPhase 2
Omaha, Nebraska
This trial is looking at a new treatment for prostate cancer that uses a radioantibody to target cancer cells. The study is divided into three parts. In Part 1, participants will receive an
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service